NCT01258309已完成3 期
Safety and Efficacy of Olopatadine Hydrochloride/Ketorolac Tromethamine Ophthalmic Solution Compared With Olopatadine Hydrochloride Ophthalmic Solution in Patients With Seasonal Allergic Conjunctivitis
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- Allergan
- 入组人数
- 129
- 主要终点
- Ocular Itching
研究概览
简要总结
This study will investigate the safety and efficacy of olopatadine hydrochloride / ketorolac tromethamine fixed dose combination ophthalmic solution compared with olopatadine hydrochloride ophthalmic solution in patients with seasonal allergic conjunctivitis.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Clinical diagnosis of seasonal allergic conjunctivitis
排除标准
- •Ocular infection or history of ocular herpes infection
- •History of retinal detachment or diabetic retinopathy
- •Prior or current use of systemic or topical steroids, NSAIDs, anticholinergics, immunosuppressants, or antihistamines
- •Ocular surgery within 8 weeks
研究组 & 干预措施
1
Experimental
olopatadine hydrochloride/ketorolac tromethamine fixed dose combination ophthalmic solution
干预措施: olopatadine hydrochloride /ketorolac tromethamine fixed dose combination ophthalmic solution (Drug)
2
Active Comparator
olopatadine hydrochloride/ketorolac tromethamine fixed dose combination ophthalmic solution
干预措施: olopatadine hydrochloride 0.1% ophthalmic solution (Drug)
结局指标
主要结局
Ocular Itching
时间窗: Day 21
次要结局
- Chemosis(Day 21)
- Hyperemia(Day 21)
- Ocular mucous discharge(Day 21)
研究者
相似试验
已完成
4 期
Effectiveness of Olopatadine HCl Ophthalmic Solution for the Treatment of Allergic Conjunctivitis in JapanAllergic ConjunctivitisNCT02251613Alcon Research50
已完成
4 期
Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric PatientsAllergic ConjunctivitisNCT01109485Alcon Research42
已完成
3 期
Study of Olopatadine HCl Ophthalmic Solutions Compared to Vehicle Using the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis in Japanese SubjectsAllergic ConjunctivitisNCT00987272Alcon Research267
已完成
不适用
Impact of olopatadine hydrochloride(allelock(R)) against scratching behavior of atopic dermatitis patients at night.Atopic dermatitisJPRN-UMIN000010519Mie University, Graduate School of Medicine25
已完成
不适用
Clinical evaluation of 0.1% olopatadine hydrochloride ophthalmic solution in pediatric patientsallergic conjunctivitsJPRN-UMIN000005931Alcon Japan Ltd.40
